Railroads
Compare Stocks
5 / 10Stock Comparison
WAB vs ITT vs TT vs HON vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Construction
Conglomerates
Industrial - Machinery
WAB vs ITT vs TT vs HON vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Railroads | Industrial - Machinery | Construction | Conglomerates | Industrial - Machinery |
| Market Cap | $45.08B | $18.43B | $103.18B | $135.04B | $79.14B |
| Revenue (TTM) | $11.51B | $4.24B | $21.60B | $36.76B | $18.32B |
| Net Income (TTM) | $1.21B | $458M | $2.90B | $4.10B | $2.44B |
| Gross Margin | 33.8% | 35.5% | 35.9% | 36.9% | 52.7% |
| Operating Margin | 16.1% | 15.9% | 18.2% | 14.9% | 19.8% |
| Forward P/E | 25.0x | 26.8x | 31.3x | 20.2x | 21.7x |
| Total Debt | $5.54B | $927M | $4.62B | $34.58B | $13.76B |
| Cash & Equiv. | $789M | $1.74B | $1.76B | $12.49B | $1.54B |
WAB vs ITT vs TT vs HON vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Westinghouse Air Br… (WAB) | 100 | 435.1 | +335.1% |
| ITT Inc. (ITT) | 100 | 357.3 | +257.3% |
| Trane Technologies … (TT) | 100 | 516.8 | +416.8% |
| Honeywell Internati… (HON) | 100 | 146.1 | +46.1% |
| Emerson Electric Co. (EMR) | 100 | 231.5 | +131.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WAB vs ITT vs TT vs HON vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WAB lags the leaders in this set but could rank higher in a more targeted comparison.
ITT is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 8.5%, EPS growth -3.0%, 3Y rev CAGR 9.6%
- PEG 0.55 vs HON's 11.03
- 8.5% revenue growth vs EMR's 3.0%
- +44.7% vs HON's +1.5%
TT ranks third and is worth considering specifically for long-term compounding.
- 8.7% 10Y total return vs WAB's 247.1%
- 13.4% margin vs WAB's 10.5%
- 13.4% ROA vs HON's 5.3%, ROIC 26.2% vs 12.6%
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.2%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.2%, current ratio 1.32x
- Lower P/E (20.2x vs 21.7x)
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (20.2x vs 21.7x) | |
| Quality / Margins | 13.4% margin vs WAB's 10.5% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.57 | |
| Dividends | 2.2% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +44.7% vs HON's +1.5% | |
| Efficiency (ROA) | 13.4% ROA vs HON's 5.3%, ROIC 26.2% vs 12.6% |
WAB vs ITT vs TT vs HON vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WAB vs ITT vs TT vs HON vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 1 of 6 categories
HON leads 1 • TT leads 1 • WAB leads 1 • ITT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 8.7x ITT's $4.2B. Profitability is closely matched — net margins range from 13.4% (TT) to 10.5% (WAB). On growth, ITT holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11.5B | $4.2B | $21.6B | $36.8B | $18.3B |
| EBITDAEarnings before interest/tax | $2.3B | $781M | $4.3B | $6.5B | $4.7B |
| Net IncomeAfter-tax profit | $1.2B | $458M | $2.9B | $4.1B | $2.4B |
| Free Cash FlowCash after capex | $1.6B | $485M | $3.2B | $4.2B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +33.8% | +35.5% | +35.9% | +36.9% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +16.1% | +15.9% | +18.2% | +14.9% | +19.8% |
| Net MarginNet income ÷ Revenue | +10.5% | +10.8% | +13.4% | +11.2% | +13.3% |
| FCF MarginFCF ÷ Revenue | +14.3% | +11.4% | +14.6% | +11.4% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.0% | +32.7% | +6.0% | -6.9% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.8% | -33.1% | -1.9% | -41.9% | +28.2% |
Valuation Metrics
HON leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.0x trailing earnings, HON trades at a 26% valuation discount to WAB's 38.9x P/E. Adjusting for growth (PEG ratio), ITT offers better value at 0.69x vs HON's 15.77x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45.1B | $18.4B | $103.2B | $135.0B | $79.1B |
| Enterprise ValueMkt cap + debt − cash | $49.8B | $17.6B | $106.0B | $157.1B | $91.4B |
| Trailing P/EPrice ÷ TTM EPS | 38.90x | 33.74x | 35.91x | 28.96x | 34.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.05x | 26.81x | 31.29x | 20.24x | 21.70x |
| PEG RatioP/E ÷ EPS growth rate | 1.51x | 0.69x | 1.20x | 15.77x | 7.74x |
| EV / EBITDAEnterprise value multiple | 21.03x | 21.28x | 25.06x | 19.75x | 18.09x |
| Price / SalesMarket cap ÷ Revenue | 4.04x | 4.68x | 4.84x | 3.61x | 4.39x |
| Price / BookPrice ÷ Book value/share | 4.06x | 4.03x | 12.12x | 8.87x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 30.08x | 33.66x | 36.70x | 25.04x | 29.67x |
Profitability & Efficiency
TT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
TT delivers a 34.7% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $11 for WAB. ITT carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), TT scores 9/9 vs WAB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.9% | +13.0% | +34.7% | +23.1% | +12.1% |
| ROA (TTM)Return on assets | +5.6% | +6.7% | +13.4% | +5.3% | +5.8% |
| ROICReturn on invested capital | +9.6% | +16.1% | +26.2% | +12.6% | +8.2% |
| ROCEReturn on capital employed | +11.7% | +16.3% | +27.2% | +12.6% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.50x | 0.23x | 0.54x | 2.24x | 0.68x |
| Net DebtTotal debt minus cash | $4.8B | -$816M | $2.9B | $22.1B | $12.2B |
| Cash & Equiv.Liquid assets | $789M | $1.7B | $1.8B | $12.5B | $1.5B |
| Total DebtShort + long-term debt | $5.5B | $927M | $4.6B | $34.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 7.41x | 8.60x | 17.21x | 3.92x | 6.46x |
Total Returns (Dividends Reinvested)
WAB leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WAB five years ago would be worth $33,309 today (with dividends reinvested), compared to $10,102 for HON. Over the past 12 months, ITT leads with a +44.7% total return vs HON's +1.5%. The 3-year compound annual growth rate (CAGR) favors WAB at 39.3% vs HON's 4.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.0% | +18.6% | +17.4% | +9.4% | +4.4% |
| 1-Year ReturnPast 12 months | +39.1% | +44.7% | +15.9% | +1.5% | +27.7% |
| 3-Year ReturnCumulative with dividends | +170.1% | +150.7% | +169.6% | +14.7% | +76.2% |
| 5-Year ReturnCumulative with dividends | +233.1% | +112.6% | +158.1% | +1.0% | +59.1% |
| 10-Year ReturnCumulative with dividends | +247.1% | +527.0% | +867.6% | +132.4% | +207.0% |
| CAGR (3Y)Annualised 3-year return | +39.3% | +35.9% | +39.2% | +4.7% | +20.8% |
Risk & Volatility
Evenly matched — WAB and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAB currently trades 96.3% from its 52-week high vs EMR's 85.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.11x | 1.23x | 0.98x | 0.74x | 1.57x |
| 52-Week HighHighest price in past year | $275.84 | $225.26 | $503.47 | $248.18 | $165.15 |
| 52-Week LowLowest price in past year | $184.26 | $141.92 | $348.06 | $186.76 | $109.53 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +91.5% | +92.6% | +85.9% | +85.6% |
| RSI (14)Momentum oscillator 0–100 | 53.8 | 47.5 | 50.5 | 44.2 | 51.4 |
| Avg Volume (50D)Average daily shares traded | 902K | 876K | 1.2M | 3.7M | 2.8M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WAB as "Buy", ITT as "Buy", TT as "Hold", HON as "Buy", EMR as "Buy". Consensus price targets imply 17.2% upside for ITT (target: $242) vs 9.5% for WAB (target: $291). For income investors, HON offers the higher dividend yield at 2.17% vs WAB's 0.38%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $291.00 | $241.67 | $522.73 | $243.83 | $161.31 |
| # AnalystsCovering analysts | 34 | 22 | 26 | 28 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | +0.7% | +0.8% | +2.2% | +1.5% |
| Dividend StreakConsecutive years of raises | 6 | 13 | 5 | 15 | 37 |
| Dividend / ShareAnnual DPS | $1.01 | $1.39 | $3.74 | $4.63 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +2.8% | +1.4% | +2.8% | +1.6% |
EMR leads in 1 of 6 categories (Income & Cash Flow). HON leads in 1 (Valuation Metrics). 2 tied.
WAB vs ITT vs TT vs HON vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WAB or ITT or TT or HON or EMR a better buy right now?
For growth investors, ITT Inc.
(ITT) is the stronger pick with 8. 5% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Honeywell International Inc. (HON) offers the better valuation at 29. 0x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Westinghouse Air Brake Technologies Corporation (WAB) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WAB or ITT or TT or HON or EMR?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 0x versus Westinghouse Air Brake Technologies Corporation at 38. 9x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ITT Inc. wins at 0. 55x versus Honeywell International Inc. 's 11. 03x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — WAB or ITT or TT or HON or EMR?
Over the past 5 years, Westinghouse Air Brake Technologies Corporation (WAB) delivered a total return of +233.
1%, compared to +1. 0% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: TT returned +867. 6% versus HON's +132. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WAB or ITT or TT or HON or EMR?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 57β — meaning EMR is approximately 111% more volatile than HON relative to the S&P 500. On balance sheet safety, ITT Inc. (ITT) carries a lower debt/equity ratio of 23% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — WAB or ITT or TT or HON or EMR?
By revenue growth (latest reported year), ITT Inc.
(ITT) is pulling ahead at 8. 5% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, WAB leads at 10. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WAB or ITT or TT or HON or EMR?
Trane Technologies plc (TT) is the more profitable company, earning 13.
7% net margin versus 10. 5% for Westinghouse Air Brake Technologies Corporation — meaning it keeps 13. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 16. 7% for WAB. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WAB or ITT or TT or HON or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ITT Inc. (ITT) is the more undervalued stock at a PEG of 0. 55x versus Honeywell International Inc. 's 11. 03x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 2x forward P/E versus 31. 3x for Trane Technologies plc — 11. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITT: 17. 2% to $241. 67.
08Which pays a better dividend — WAB or ITT or TT or HON or EMR?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 2%, versus 0. 4% for Westinghouse Air Brake Technologies Corporation (WAB).
09Is WAB or ITT or TT or HON or EMR better for a retirement portfolio?
For long-horizon retirement investors, Trane Technologies plc (TT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
98), 0. 8% yield, +867. 6% 10Y return). Both have compounded well over 10 years (TT: +867. 6%, WAB: +247. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WAB and ITT and TT and HON and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
ITT, TT, HON, EMR pay a dividend while WAB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.